Ongoing research focuses on the the mechanism of leprosy transmission as well as the identification of patients at high risk of infection in order to improve disease prevention and to treat infected individuals earlier.   Identification of alternatives to existing drugs, such as rifampicin is also critical in so far as these agents may be contraindicated either because of toxicity or resistance.
Leprosy future or investigational therapies
Leprosy primary prevention
Tuberculosis future or investigational therapies
Leprosy tertiary prevention
HIV coinfection with tuberculosis prevention
Contact Dermatitis primary prevention
Tuberculosis secondary prevention
HIV AIDS medical therapy